Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Recovery from the COVID-19 pandemic by mass vaccination: emergent lessons from the United States and India

View ORCID ProfileEdwin Michael, Ken Newcomb, Anuj Mubayi, Imran Mahmood
doi: https://doi.org/10.1101/2021.05.26.21257847
Edwin Michael
aGlobal Health Infectious Disease Research, University of South Florida, Tampa, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edwin Michael
  • For correspondence: emichael443@usf.edu
Ken Newcomb
aGlobal Health Infectious Disease Research, University of South Florida, Tampa, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anuj Mubayi
bPRECISIONheor, Los Angeles, CA, USA
cCenter for Collaborative Studies in Mathematical Biology, Illinois State University, Normal, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imran Mahmood
aGlobal Health Infectious Disease Research, University of South Florida, Tampa, FL, USA
dSchool of Electrical Engineering and Computer Science(SEECS), National University of Sciences and Technology (NUST), Islamabad 44000, Pakistan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The advent of vaccinations has heightened global optimism that the end of the SARS-CoV-2 pandemic could be in sight. However, concerns, including the impact of variations in the rates of vaccination between countries, raise questions about the use of mass vaccination for accomplishing a quick recovery from the contagion. Here, we used a SEIR-based model calibrated to data on the pandemic and vaccinations reported for the United States (US) and India to gain strategic insights into using mass vaccinations for ending COVID-19. We estimate that while up to 65% of the US population is already immune to the virus due to the recent rapid mass vaccinations carried out, only 13% of the Indian population may be immune currently owing to a slow rate of vaccination and the effect of a stricter lockdown imposed to curb the first wave of the pandemic. We project that due to the higher immune to susceptible ratio already achieved in the US, the pandemic will only decline if the present rates of vaccinations and social mitigations are continued and remain effective. By contrast, the recent loosening of social measures coupled with a slow rate of vaccination is the chief reason for the virus resurgence in India, with only immediate lockdowns coupled with ramping up of vaccinations providing the means to control the present wave. These results highlight that using mass vaccination to achieve a speedy recovery from the SARS-CoV-2 pandemic will depend crucially on the ability to carry out national vaccinations as rapidly as possible.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is a modelling study of publically reported data, so no approval or exemption required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Author Contributions: E.M. and K.N. designed research; K.N. performed research; E.M., K.N., A.M., and I.M. analyzed data; E.M., K.N., A.M., and I.M. wrote the paper.

  • The authors declare no competing interest.

Data Availability

The computation system, data and model parameters are available at: https://github.com/EdwinMichaelLab/COVID-SEIR-India

https://github.com/EdwinMichaelLab/COVID-SEIR-India

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted May 27, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Recovery from the COVID-19 pandemic by mass vaccination: emergent lessons from the United States and India
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Recovery from the COVID-19 pandemic by mass vaccination: emergent lessons from the United States and India
Edwin Michael, Ken Newcomb, Anuj Mubayi, Imran Mahmood
medRxiv 2021.05.26.21257847; doi: https://doi.org/10.1101/2021.05.26.21257847
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Recovery from the COVID-19 pandemic by mass vaccination: emergent lessons from the United States and India
Edwin Michael, Ken Newcomb, Anuj Mubayi, Imran Mahmood
medRxiv 2021.05.26.21257847; doi: https://doi.org/10.1101/2021.05.26.21257847

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1970)
  • Dentistry and Oral Medicine (253)
  • Dermatology (188)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11134)
  • Forensic Medicine (8)
  • Gastroenterology (632)
  • Genetic and Genomic Medicine (3205)
  • Geriatric Medicine (310)
  • Health Economics (570)
  • Health Informatics (2055)
  • Health Policy (864)
  • Health Systems and Quality Improvement (793)
  • Hematology (311)
  • HIV/AIDS (687)
  • Infectious Diseases (except HIV/AIDS) (12750)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (320)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3006)
  • Nursing (167)
  • Nutrition (466)
  • Obstetrics and Gynecology (592)
  • Occupational and Environmental Health (614)
  • Oncology (1566)
  • Ophthalmology (478)
  • Orthopedics (189)
  • Otolaryngology (267)
  • Pain Medicine (204)
  • Palliative Medicine (57)
  • Pathology (404)
  • Pediatrics (916)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (357)
  • Psychiatry and Clinical Psychology (2811)
  • Public and Global Health (5624)
  • Radiology and Imaging (1104)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (765)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (291)
  • Surgery (351)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)